Eliminating Meningitis Across Africa's Meningitis Belt
2016
This case study describes the development and roll-out of an effective preventive vaccine to prevent meningitis A epidemics in Africa. In 2001, a collaboration with the Program for Appropriate Technology in Health (PATH), the World Health Organization (WHO) and the Gates Foundation established the Meningitis Vaccine Project (MVP) to develop the new vaccine, “MenAfriVac.” This case details the approach taken to develop, test, license, and introduce the vaccine; its impact on meningitis incidence; and the costs of bringing the vaccine to market and rolling out the vaccine in mass vaccination campaigns.
This case study is part of Millions Saved: New Cases of Proven Success in Global Health, a collection of case studies produced by the Center for Global Development that profiles 18 remarkable cases in which large-scale efforts to improve health in low- and middle-income countries succeeded, and 4 examples of promising interventions that fell short of their health targets when scaled-up in real world conditions. The cases featured on the website are shortened versions of the respective book chapters in the print edition.
Eliminating Meningitis Across Africa's Meningitis Belt
Source:
Glassman A, Temin M. Eliminating Meningitis Across Africa’s Meningitis Belt. Millions Saved: New Cases of Proven Success in Global Health. Center for Global Development 2016. http://millionssaved.cgdev.org/case-studies/eliminating-meningitis-across-africas-meningitis-belt.